database,exposure,outcomeCategory,Disease,denomPatid,denomIndexExp,timeWindow,numer,prevPct
MPCD,DMARD,Cancer,Hematologic Cancer,381,445,12 months,4,0.8988764045
MPCD,DMARD,Cancer,Hematologic Cancer,381,445,24 months,4,0.8988764045
MPCD,DMARD,Cancer,Hematologic Cancer,381,445,36 months,4,0.8988764045
MPCD,DMARD,Cancer,Hematologic Cancer,381,445,AS cohort entry to exposure,3,0.6741573034
MPCD,DMARD,Cancer,Solid Cancer,381,445,12 months,16,3.595505618
MPCD,DMARD,Cancer,Solid Cancer,381,445,24 months,21,4.7191011236
MPCD,DMARD,Cancer,Solid Cancer,381,445,36 months,21,4.7191011236
MPCD,DMARD,Cancer,Solid Cancer,381,445,AS cohort entry to exposure,9,2.0224719101
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,381,445,12 months,5,1.1235955056
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,381,445,24 months,5,1.1235955056
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,381,445,36 months,5,1.1235955056
MPCD,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,381,445,AS cohort entry to exposure,2,0.4494382022
MPCD,DMARD,Cardiac disease,Conduction Block,381,445,12 months,1,0.2247191011
MPCD,DMARD,Cardiac disease,Conduction Block,381,445,24 months,1,0.2247191011
MPCD,DMARD,Cardiac disease,Conduction Block,381,445,36 months,1,0.2247191011
MPCD,DMARD,Cardiac disease,Conduction Block,381,445,AS cohort entry to exposure,0,0
MPCD,DMARD,Infection,Hospitalized infection,381,445,12 months,4,0.8988764045
MPCD,DMARD,Infection,Hospitalized infection,381,445,24 months,7,1.5730337079
MPCD,DMARD,Infection,Hospitalized infection,381,445,36 months,12,2.6966292135
MPCD,DMARD,Infection,Hospitalized infection,381,445,AS cohort entry to exposure,5,1.1235955056
MPCD,DMARD,Infection,Opportunistic infection,381,445,12 months,5,1.1235955056
MPCD,DMARD,Infection,Opportunistic infection,381,445,24 months,8,1.797752809
MPCD,DMARD,Infection,Opportunistic infection,381,445,36 months,12,2.6966292135
MPCD,DMARD,Infection,Opportunistic infection,381,445,AS cohort entry to exposure,4,0.8988764045
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,381,445,12 months,14,3.1460674157
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,381,445,24 months,16,3.595505618
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,381,445,36 months,16,3.595505618
MPCD,DMARD,Inflammatory bowel disease,Crohn’s Disease,381,445,AS cohort entry to exposure,10,2.2471910112
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,381,445,12 months,8,1.797752809
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,381,445,24 months,9,2.0224719101
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,381,445,36 months,9,2.0224719101
MPCD,DMARD,Inflammatory bowel disease,Ulcerative Colitis,381,445,AS cohort entry to exposure,4,0.8988764045
MPCD,DMARD,Kidney disease,IgA nephropathy,381,445,12 months,1,0.2247191011
MPCD,DMARD,Kidney disease,IgA nephropathy,381,445,24 months,1,0.2247191011
MPCD,DMARD,Kidney disease,IgA nephropathy,381,445,36 months,1,0.2247191011
MPCD,DMARD,Kidney disease,IgA nephropathy,381,445,AS cohort entry to exposure,1,0.2247191011
MPCD,DMARD,Lung disease,Restrictive lung disease ,381,445,12 months,1,0.2247191011
MPCD,DMARD,Lung disease,Restrictive lung disease ,381,445,24 months,2,0.4494382022
MPCD,DMARD,Lung disease,Restrictive lung disease ,381,445,36 months,3,0.6741573034
MPCD,DMARD,Lung disease,Restrictive lung disease ,381,445,AS cohort entry to exposure,2,0.4494382022
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,381,445,12 months,4,0.8988764045
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,381,445,24 months,4,0.8988764045
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,381,445,36 months,4,0.8988764045
MPCD,DMARD,Osteoporotic fracture,Clinical vertebral fracture,381,445,AS cohort entry to exposure,2,0.4494382022
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,381,445,12 months,9,2.0224719101
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,381,445,24 months,12,2.6966292135
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,381,445,36 months,16,3.595505618
MPCD,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,381,445,AS cohort entry to exposure,3,0.6741573034
MPCD,DMARD,PsO/PsA,Psoriasis,381,445,12 months,13,2.9213483146
MPCD,DMARD,PsO/PsA,Psoriasis,381,445,24 months,14,3.1460674157
MPCD,DMARD,PsO/PsA,Psoriasis,381,445,36 months,16,3.595505618
MPCD,DMARD,PsO/PsA,Psoriasis,381,445,AS cohort entry to exposure,14,3.1460674157
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,381,445,12 months,33,7.4157303371
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,381,445,24 months,37,8.3146067416
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,381,445,36 months,39,8.7640449438
MPCD,DMARD,PsO/PsA,Psoriatic arthritis,381,445,AS cohort entry to exposure,23,5.1685393258
MPCD,DMARD,Uveitis,Uveitis,381,445,12 months,21,4.7191011236
MPCD,DMARD,Uveitis,Uveitis,381,445,24 months,26,5.8426966292
MPCD,DMARD,Uveitis,Uveitis,381,445,36 months,27,6.0674157303
MPCD,DMARD,Uveitis,Uveitis,381,445,AS cohort entry to exposure,19,4.2696629213
MPCD,NSAID,Cancer,Hematologic Cancer,587,799,12 months,3,0.3754693367
MPCD,NSAID,Cancer,Hematologic Cancer,587,799,24 months,3,0.3754693367
MPCD,NSAID,Cancer,Hematologic Cancer,587,799,36 months,3,0.3754693367
MPCD,NSAID,Cancer,Hematologic Cancer,587,799,AS cohort entry to exposure,3,0.3754693367
MPCD,NSAID,Cancer,Solid Cancer,587,799,12 months,25,3.1289111389
MPCD,NSAID,Cancer,Solid Cancer,587,799,24 months,34,4.2553191489
MPCD,NSAID,Cancer,Solid Cancer,587,799,36 months,35,4.3804755945
MPCD,NSAID,Cancer,Solid Cancer,587,799,AS cohort entry to exposure,20,2.5031289111
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,587,799,12 months,4,0.5006257822
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,587,799,24 months,5,0.6257822278
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,587,799,36 months,5,0.6257822278
MPCD,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,587,799,AS cohort entry to exposure,4,0.5006257822
MPCD,NSAID,Cardiac disease,Conduction Block,587,799,12 months,5,0.6257822278
MPCD,NSAID,Cardiac disease,Conduction Block,587,799,24 months,6,0.7509386733
MPCD,NSAID,Cardiac disease,Conduction Block,587,799,36 months,6,0.7509386733
MPCD,NSAID,Cardiac disease,Conduction Block,587,799,AS cohort entry to exposure,2,0.2503128911
MPCD,NSAID,Infection,Hospitalized infection,587,799,12 months,3,0.3754693367
MPCD,NSAID,Infection,Hospitalized infection,587,799,24 months,8,1.0012515645
MPCD,NSAID,Infection,Hospitalized infection,587,799,36 months,10,1.2515644556
MPCD,NSAID,Infection,Hospitalized infection,587,799,AS cohort entry to exposure,0,0
MPCD,NSAID,Infection,Opportunistic infection,587,799,12 months,1,0.1251564456
MPCD,NSAID,Infection,Opportunistic infection,587,799,24 months,3,0.3754693367
MPCD,NSAID,Infection,Opportunistic infection,587,799,36 months,5,0.6257822278
MPCD,NSAID,Infection,Opportunistic infection,587,799,AS cohort entry to exposure,3,0.3754693367
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,587,799,12 months,10,1.2515644556
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,587,799,24 months,13,1.6270337922
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,587,799,36 months,14,1.7521902378
MPCD,NSAID,Inflammatory bowel disease,Crohn’s Disease,587,799,AS cohort entry to exposure,9,1.12640801
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,587,799,12 months,7,0.8760951189
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,587,799,24 months,8,1.0012515645
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,587,799,36 months,8,1.0012515645
MPCD,NSAID,Inflammatory bowel disease,Ulcerative Colitis,587,799,AS cohort entry to exposure,11,1.3767209011
MPCD,NSAID,Kidney disease,IgA nephropathy,587,799,12 months,3,0.3754693367
MPCD,NSAID,Kidney disease,IgA nephropathy,587,799,24 months,4,0.5006257822
MPCD,NSAID,Kidney disease,IgA nephropathy,587,799,36 months,4,0.5006257822
MPCD,NSAID,Kidney disease,IgA nephropathy,587,799,AS cohort entry to exposure,1,0.1251564456
MPCD,NSAID,Lung disease,Restrictive lung disease ,587,799,12 months,9,1.12640801
MPCD,NSAID,Lung disease,Restrictive lung disease ,587,799,24 months,14,1.7521902378
MPCD,NSAID,Lung disease,Restrictive lung disease ,587,799,36 months,16,2.0025031289
MPCD,NSAID,Lung disease,Restrictive lung disease ,587,799,AS cohort entry to exposure,6,0.7509386733
MPCD,NSAID,Neurological Disease,Spinal Cord compression,587,799,12 months,2,0.2503128911
MPCD,NSAID,Neurological Disease,Spinal Cord compression,587,799,24 months,3,0.3754693367
MPCD,NSAID,Neurological Disease,Spinal Cord compression,587,799,36 months,3,0.3754693367
MPCD,NSAID,Neurological Disease,Spinal Cord compression,587,799,AS cohort entry to exposure,1,0.1251564456
MPCD,NSAID,Osteoporotic fracture,Clinical vertebral fracture,587,799,12 months,4,0.5006257822
MPCD,NSAID,Osteoporotic fracture,Clinical vertebral fracture,587,799,24 months,4,0.5006257822
MPCD,NSAID,Osteoporotic fracture,Clinical vertebral fracture,587,799,36 months,4,0.5006257822
MPCD,NSAID,Osteoporotic fracture,Clinical vertebral fracture,587,799,AS cohort entry to exposure,1,0.1251564456
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,587,799,12 months,18,2.25281602
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,587,799,24 months,23,2.8785982478
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,587,799,36 months,25,3.1289111389
MPCD,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,587,799,AS cohort entry to exposure,13,1.6270337922
MPCD,NSAID,PsO/PsA,Psoriasis,587,799,12 months,13,1.6270337922
MPCD,NSAID,PsO/PsA,Psoriasis,587,799,24 months,16,2.0025031289
MPCD,NSAID,PsO/PsA,Psoriasis,587,799,36 months,26,3.2540675845
MPCD,NSAID,PsO/PsA,Psoriasis,587,799,AS cohort entry to exposure,17,2.1276595745
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,587,799,12 months,21,2.6282853567
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,587,799,24 months,24,3.0037546934
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,587,799,36 months,27,3.37922403
MPCD,NSAID,PsO/PsA,Psoriatic arthritis,587,799,AS cohort entry to exposure,17,2.1276595745
MPCD,NSAID,Uveitis,Uveitis,587,799,12 months,36,4.5056320401
MPCD,NSAID,Uveitis,Uveitis,587,799,24 months,40,5.0062578223
MPCD,NSAID,Uveitis,Uveitis,587,799,36 months,40,5.0062578223
MPCD,NSAID,Uveitis,Uveitis,587,799,AS cohort entry to exposure,35,4.3804755945
MPCD,No exposure,Cancer,Hematologic Cancer,1160,1160,12 months,10,0.8620689655
MPCD,No exposure,Cancer,Hematologic Cancer,1160,1160,24 months,11,0.9482758621
MPCD,No exposure,Cancer,Hematologic Cancer,1160,1160,36 months,13,1.1206896552
MPCD,No exposure,Cancer,Hematologic Cancer,1160,1160,AS cohort entry to exposure,1,0.0862068966
MPCD,No exposure,Cancer,Solid Cancer,1160,1160,12 months,63,5.4310344828
MPCD,No exposure,Cancer,Solid Cancer,1160,1160,24 months,85,7.3275862069
MPCD,No exposure,Cancer,Solid Cancer,1160,1160,36 months,96,8.275862069
MPCD,No exposure,Cancer,Solid Cancer,1160,1160,AS cohort entry to exposure,4,0.3448275862
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1160,1160,12 months,31,2.6724137931
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1160,1160,24 months,36,3.1034482759
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1160,1160,36 months,40,3.4482758621
MPCD,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1160,1160,AS cohort entry to exposure,2,0.1724137931
MPCD,No exposure,Cardiac disease,Conduction Block,1160,1160,12 months,11,0.9482758621
MPCD,No exposure,Cardiac disease,Conduction Block,1160,1160,24 months,17,1.4655172414
MPCD,No exposure,Cardiac disease,Conduction Block,1160,1160,36 months,19,1.6379310345
MPCD,No exposure,Cardiac disease,Conduction Block,1160,1160,AS cohort entry to exposure,1,0.0862068966
MPCD,No exposure,Cardiac disease,Myocardial infarction,1160,1160,12 months,1,0.0862068966
MPCD,No exposure,Cardiac disease,Myocardial infarction,1160,1160,24 months,4,0.3448275862
MPCD,No exposure,Cardiac disease,Myocardial infarction,1160,1160,36 months,5,0.4310344828
MPCD,No exposure,Cardiac disease,Myocardial infarction,1160,1160,AS cohort entry to exposure,0,0
MPCD,No exposure,Infection,Hospitalized infection,1160,1160,12 months,28,2.4137931034
MPCD,No exposure,Infection,Hospitalized infection,1160,1160,24 months,52,4.4827586207
MPCD,No exposure,Infection,Hospitalized infection,1160,1160,36 months,63,5.4310344828
MPCD,No exposure,Infection,Hospitalized infection,1160,1160,AS cohort entry to exposure,0,0
MPCD,No exposure,Infection,Opportunistic infection,1160,1160,12 months,8,0.6896551724
MPCD,No exposure,Infection,Opportunistic infection,1160,1160,24 months,13,1.1206896552
MPCD,No exposure,Infection,Opportunistic infection,1160,1160,36 months,16,1.3793103448
MPCD,No exposure,Infection,Opportunistic infection,1160,1160,AS cohort entry to exposure,3,0.2586206897
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,1160,1160,12 months,29,2.5
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,1160,1160,24 months,35,3.0172413793
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,1160,1160,36 months,42,3.6206896552
MPCD,No exposure,Inflammatory bowel disease,Crohn’s Disease,1160,1160,AS cohort entry to exposure,9,0.775862069
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1160,1160,12 months,25,2.1551724138
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1160,1160,24 months,28,2.4137931034
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1160,1160,36 months,30,2.5862068966
MPCD,No exposure,Inflammatory bowel disease,Ulcerative Colitis,1160,1160,AS cohort entry to exposure,1,0.0862068966
MPCD,No exposure,Kidney disease,Amyloidosis,1160,1160,12 months,2,0.1724137931
MPCD,No exposure,Kidney disease,Amyloidosis,1160,1160,24 months,3,0.2586206897
MPCD,No exposure,Kidney disease,Amyloidosis,1160,1160,36 months,4,0.3448275862
MPCD,No exposure,Kidney disease,Amyloidosis,1160,1160,AS cohort entry to exposure,0,0
MPCD,No exposure,Kidney disease,IgA nephropathy,1160,1160,12 months,0,0
MPCD,No exposure,Kidney disease,IgA nephropathy,1160,1160,24 months,1,0.0862068966
MPCD,No exposure,Kidney disease,IgA nephropathy,1160,1160,36 months,3,0.2586206897
MPCD,No exposure,Kidney disease,IgA nephropathy,1160,1160,AS cohort entry to exposure,0,0
MPCD,No exposure,Kidney disease,Nephrotic syndrome,1160,1160,12 months,0,0
MPCD,No exposure,Kidney disease,Nephrotic syndrome,1160,1160,24 months,1,0.0862068966
MPCD,No exposure,Kidney disease,Nephrotic syndrome,1160,1160,36 months,1,0.0862068966
MPCD,No exposure,Kidney disease,Nephrotic syndrome,1160,1160,AS cohort entry to exposure,0,0
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,1160,1160,12 months,0,0
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,1160,1160,24 months,1,0.0862068966
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,1160,1160,36 months,1,0.0862068966
MPCD,No exposure,Lung disease,Apical Pulmonary fibrosis,1160,1160,AS cohort entry to exposure,0,0
MPCD,No exposure,Lung disease,Restrictive lung disease ,1160,1160,12 months,18,1.5517241379
MPCD,No exposure,Lung disease,Restrictive lung disease ,1160,1160,24 months,22,1.8965517241
MPCD,No exposure,Lung disease,Restrictive lung disease ,1160,1160,36 months,26,2.2413793103
MPCD,No exposure,Lung disease,Restrictive lung disease ,1160,1160,AS cohort entry to exposure,1,0.0862068966
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,1160,1160,12 months,1,0.0862068966
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,1160,1160,24 months,2,0.1724137931
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,1160,1160,36 months,2,0.1724137931
MPCD,No exposure,Neurological Disease,Cauda Equina syndrome,1160,1160,AS cohort entry to exposure,0,0
MPCD,No exposure,Neurological Disease,Spinal Cord compression,1160,1160,12 months,2,0.1724137931
MPCD,No exposure,Neurological Disease,Spinal Cord compression,1160,1160,24 months,2,0.1724137931
MPCD,No exposure,Neurological Disease,Spinal Cord compression,1160,1160,36 months,3,0.2586206897
MPCD,No exposure,Neurological Disease,Spinal Cord compression,1160,1160,AS cohort entry to exposure,1,0.0862068966
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1160,1160,12 months,24,2.0689655172
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1160,1160,24 months,38,3.275862069
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1160,1160,36 months,39,3.3620689655
MPCD,No exposure,Osteoporotic fracture,Clinical vertebral fracture,1160,1160,AS cohort entry to exposure,0,0
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1160,1160,12 months,22,1.8965517241
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1160,1160,24 months,40,3.4482758621
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1160,1160,36 months,46,3.9655172414
MPCD,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1160,1160,AS cohort entry to exposure,2,0.1724137931
MPCD,No exposure,PsO/PsA,Psoriasis,1160,1160,12 months,25,2.1551724138
MPCD,No exposure,PsO/PsA,Psoriasis,1160,1160,24 months,34,2.9310344828
MPCD,No exposure,PsO/PsA,Psoriasis,1160,1160,36 months,36,3.1034482759
MPCD,No exposure,PsO/PsA,Psoriasis,1160,1160,AS cohort entry to exposure,4,0.3448275862
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,1160,1160,12 months,45,3.8793103448
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,1160,1160,24 months,52,4.4827586207
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,1160,1160,36 months,57,4.9137931034
MPCD,No exposure,PsO/PsA,Psoriatic arthritis,1160,1160,AS cohort entry to exposure,18,1.5517241379
MPCD,No exposure,Uveitis,Uveitis,1160,1160,12 months,58,5
MPCD,No exposure,Uveitis,Uveitis,1160,1160,24 months,75,6.4655172414
MPCD,No exposure,Uveitis,Uveitis,1160,1160,36 months,79,6.8103448276
MPCD,No exposure,Uveitis,Uveitis,1160,1160,AS cohort entry to exposure,16,1.3793103448
MPCD,TNF,Cancer,Hematologic Cancer,856,994,12 months,4,0.4024144869
MPCD,TNF,Cancer,Hematologic Cancer,856,994,24 months,5,0.5030181087
MPCD,TNF,Cancer,Hematologic Cancer,856,994,36 months,5,0.5030181087
MPCD,TNF,Cancer,Hematologic Cancer,856,994,AS cohort entry to exposure,4,0.4024144869
MPCD,TNF,Cancer,Solid Cancer,856,994,12 months,23,2.3138832998
MPCD,TNF,Cancer,Solid Cancer,856,994,24 months,29,2.9175050302
MPCD,TNF,Cancer,Solid Cancer,856,994,36 months,32,3.2193158954
MPCD,TNF,Cancer,Solid Cancer,856,994,AS cohort entry to exposure,16,1.6096579477
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,856,994,12 months,16,1.6096579477
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,856,994,24 months,18,1.8108651911
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,856,994,36 months,18,1.8108651911
MPCD,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,856,994,AS cohort entry to exposure,13,1.3078470825
MPCD,TNF,Cardiac disease,Conduction Block,856,994,12 months,5,0.5030181087
MPCD,TNF,Cardiac disease,Conduction Block,856,994,24 months,5,0.5030181087
MPCD,TNF,Cardiac disease,Conduction Block,856,994,36 months,5,0.5030181087
MPCD,TNF,Cardiac disease,Conduction Block,856,994,AS cohort entry to exposure,4,0.4024144869
MPCD,TNF,Cardiac disease,Myocardial infarction,856,994,12 months,1,0.1006036217
MPCD,TNF,Cardiac disease,Myocardial infarction,856,994,24 months,3,0.3018108652
MPCD,TNF,Cardiac disease,Myocardial infarction,856,994,36 months,3,0.3018108652
MPCD,TNF,Cardiac disease,Myocardial infarction,856,994,AS cohort entry to exposure,1,0.1006036217
MPCD,TNF,Infection,Hospitalized infection,856,994,12 months,7,0.7042253521
MPCD,TNF,Infection,Hospitalized infection,856,994,24 months,10,1.0060362173
MPCD,TNF,Infection,Hospitalized infection,856,994,36 months,12,1.2072434608
MPCD,TNF,Infection,Hospitalized infection,856,994,AS cohort entry to exposure,4,0.4024144869
MPCD,TNF,Infection,Opportunistic infection,856,994,12 months,13,1.3078470825
MPCD,TNF,Infection,Opportunistic infection,856,994,24 months,19,1.9114688129
MPCD,TNF,Infection,Opportunistic infection,856,994,36 months,21,2.1126760563
MPCD,TNF,Infection,Opportunistic infection,856,994,AS cohort entry to exposure,12,1.2072434608
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,856,994,12 months,73,7.3440643863
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,856,994,24 months,77,7.7464788732
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,856,994,36 months,81,8.1488933602
MPCD,TNF,Inflammatory bowel disease,Crohn’s Disease,856,994,AS cohort entry to exposure,66,6.6398390342
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,856,994,12 months,30,3.0181086519
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,856,994,24 months,33,3.3199195171
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,856,994,36 months,34,3.4205231388
MPCD,TNF,Inflammatory bowel disease,Ulcerative Colitis,856,994,AS cohort entry to exposure,29,2.9175050302
MPCD,TNF,Kidney disease,Amyloidosis,856,994,12 months,2,0.2012072435
MPCD,TNF,Kidney disease,Amyloidosis,856,994,24 months,2,0.2012072435
MPCD,TNF,Kidney disease,Amyloidosis,856,994,36 months,2,0.2012072435
MPCD,TNF,Kidney disease,Amyloidosis,856,994,AS cohort entry to exposure,1,0.1006036217
MPCD,TNF,Kidney disease,IgA nephropathy,856,994,12 months,4,0.4024144869
MPCD,TNF,Kidney disease,IgA nephropathy,856,994,24 months,4,0.4024144869
MPCD,TNF,Kidney disease,IgA nephropathy,856,994,36 months,4,0.4024144869
MPCD,TNF,Kidney disease,IgA nephropathy,856,994,AS cohort entry to exposure,3,0.3018108652
MPCD,TNF,Kidney disease,Nephrotic syndrome,856,994,12 months,2,0.2012072435
MPCD,TNF,Kidney disease,Nephrotic syndrome,856,994,24 months,2,0.2012072435
MPCD,TNF,Kidney disease,Nephrotic syndrome,856,994,36 months,2,0.2012072435
MPCD,TNF,Kidney disease,Nephrotic syndrome,856,994,AS cohort entry to exposure,0,0
MPCD,TNF,Lung disease,Restrictive lung disease ,856,994,12 months,9,0.9054325956
MPCD,TNF,Lung disease,Restrictive lung disease ,856,994,24 months,12,1.2072434608
MPCD,TNF,Lung disease,Restrictive lung disease ,856,994,36 months,13,1.3078470825
MPCD,TNF,Lung disease,Restrictive lung disease ,856,994,AS cohort entry to exposure,7,0.7042253521
MPCD,TNF,Neurological Disease,Spinal Cord compression,856,994,12 months,1,0.1006036217
MPCD,TNF,Neurological Disease,Spinal Cord compression,856,994,24 months,1,0.1006036217
MPCD,TNF,Neurological Disease,Spinal Cord compression,856,994,36 months,1,0.1006036217
MPCD,TNF,Neurological Disease,Spinal Cord compression,856,994,AS cohort entry to exposure,0,0
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,856,994,12 months,14,1.4084507042
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,856,994,24 months,15,1.509054326
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,856,994,36 months,15,1.509054326
MPCD,TNF,Osteoporotic fracture,Clinical vertebral fracture,856,994,AS cohort entry to exposure,8,0.8048289738
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,856,994,12 months,18,1.8108651911
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,856,994,24 months,24,2.4144869215
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,856,994,36 months,24,2.4144869215
MPCD,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,856,994,AS cohort entry to exposure,11,1.106639839
MPCD,TNF,PsO/PsA,Psoriasis,856,994,12 months,46,4.6277665996
MPCD,TNF,PsO/PsA,Psoriasis,856,994,24 months,57,5.7344064386
MPCD,TNF,PsO/PsA,Psoriasis,856,994,36 months,58,5.8350100604
MPCD,TNF,PsO/PsA,Psoriasis,856,994,AS cohort entry to exposure,31,3.1187122736
MPCD,TNF,PsO/PsA,Psoriatic arthritis,856,994,12 months,82,8.2494969819
MPCD,TNF,PsO/PsA,Psoriatic arthritis,856,994,24 months,97,9.7585513078
MPCD,TNF,PsO/PsA,Psoriatic arthritis,856,994,36 months,101,10.160965795
MPCD,TNF,PsO/PsA,Psoriatic arthritis,856,994,AS cohort entry to exposure,71,7.1428571429
MPCD,TNF,Uveitis,Uveitis,856,994,12 months,69,6.9416498994
MPCD,TNF,Uveitis,Uveitis,856,994,24 months,81,8.1488933602
MPCD,TNF,Uveitis,Uveitis,856,994,36 months,83,8.3501006036
MPCD,TNF,Uveitis,Uveitis,856,994,AS cohort entry to exposure,55,5.5331991952
Marketscan,DMARD,Cancer,Hematologic Cancer,1550,1760,12 months,11,0.625
Marketscan,DMARD,Cancer,Hematologic Cancer,1550,1760,24 months,15,0.8522727273
Marketscan,DMARD,Cancer,Hematologic Cancer,1550,1760,36 months,16,0.9090909091
Marketscan,DMARD,Cancer,Hematologic Cancer,1550,1760,AS cohort entry to exposure,11,0.625
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1550,1760,12 months,13,0.7386363636
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1550,1760,24 months,24,1.3636363636
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1550,1760,36 months,29,1.6477272727
Marketscan,DMARD,Cancer,Non Melanoma Skin Cancer,1550,1760,AS cohort entry to exposure,11,0.625
Marketscan,DMARD,Cancer,Solid Cancer,1550,1760,12 months,69,3.9204545455
Marketscan,DMARD,Cancer,Solid Cancer,1550,1760,24 months,75,4.2613636364
Marketscan,DMARD,Cancer,Solid Cancer,1550,1760,36 months,81,4.6022727273
Marketscan,DMARD,Cancer,Solid Cancer,1550,1760,AS cohort entry to exposure,47,2.6704545455
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1550,1760,12 months,15,0.8522727273
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1550,1760,24 months,21,1.1931818182
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1550,1760,36 months,26,1.4772727273
Marketscan,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1550,1760,AS cohort entry to exposure,15,0.8522727273
Marketscan,DMARD,Cardiac disease,Conduction Block,1550,1760,12 months,18,1.0227272727
Marketscan,DMARD,Cardiac disease,Conduction Block,1550,1760,24 months,25,1.4204545455
Marketscan,DMARD,Cardiac disease,Conduction Block,1550,1760,36 months,28,1.5909090909
Marketscan,DMARD,Cardiac disease,Conduction Block,1550,1760,AS cohort entry to exposure,12,0.6818181818
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1550,1760,12 months,3,0.1704545455
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1550,1760,24 months,5,0.2840909091
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1550,1760,36 months,7,0.3977272727
Marketscan,DMARD,Cardiac disease,Myocardial infarction,1550,1760,AS cohort entry to exposure,3,0.1704545455
Marketscan,DMARD,Infection,Hospitalized infection,1550,1760,12 months,53,3.0113636364
Marketscan,DMARD,Infection,Hospitalized infection,1550,1760,24 months,82,4.6590909091
Marketscan,DMARD,Infection,Hospitalized infection,1550,1760,36 months,91,5.1704545455
Marketscan,DMARD,Infection,Hospitalized infection,1550,1760,AS cohort entry to exposure,45,2.5568181818
Marketscan,DMARD,Infection,Opportunistic infection,1550,1760,12 months,24,1.3636363636
Marketscan,DMARD,Infection,Opportunistic infection,1550,1760,24 months,34,1.9318181818
Marketscan,DMARD,Infection,Opportunistic infection,1550,1760,36 months,42,2.3863636364
Marketscan,DMARD,Infection,Opportunistic infection,1550,1760,AS cohort entry to exposure,17,0.9659090909
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1550,1760,12 months,60,3.4090909091
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1550,1760,24 months,70,3.9772727273
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1550,1760,36 months,74,4.2045454545
Marketscan,DMARD,Inflammatory bowel disease,Crohn’s Disease,1550,1760,AS cohort entry to exposure,55,3.125
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1550,1760,12 months,44,2.5
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1550,1760,24 months,52,2.9545454545
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1550,1760,36 months,55,3.125
Marketscan,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1550,1760,AS cohort entry to exposure,26,1.4772727273
Marketscan,DMARD,Kidney disease,Amyloidosis,1550,1760,12 months,0,0
Marketscan,DMARD,Kidney disease,Amyloidosis,1550,1760,24 months,2,0.1136363636
Marketscan,DMARD,Kidney disease,Amyloidosis,1550,1760,36 months,2,0.1136363636
Marketscan,DMARD,Kidney disease,Amyloidosis,1550,1760,AS cohort entry to exposure,0,0
Marketscan,DMARD,Kidney disease,IgA nephropathy,1550,1760,12 months,0,0
Marketscan,DMARD,Kidney disease,IgA nephropathy,1550,1760,24 months,0,0
Marketscan,DMARD,Kidney disease,IgA nephropathy,1550,1760,36 months,2,0.1136363636
Marketscan,DMARD,Kidney disease,IgA nephropathy,1550,1760,AS cohort entry to exposure,1,0.0568181818
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1550,1760,12 months,0,0
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1550,1760,24 months,0,0
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1550,1760,36 months,1,0.0568181818
Marketscan,DMARD,Kidney disease,Nephrotic syndrome,1550,1760,AS cohort entry to exposure,0,0
Marketscan,DMARD,Lung disease,Interstitial lung disease,1550,1760,12 months,2,0.1136363636
Marketscan,DMARD,Lung disease,Interstitial lung disease,1550,1760,24 months,2,0.1136363636
Marketscan,DMARD,Lung disease,Interstitial lung disease,1550,1760,36 months,3,0.1704545455
Marketscan,DMARD,Lung disease,Interstitial lung disease,1550,1760,AS cohort entry to exposure,1,0.0568181818
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1550,1760,12 months,11,0.625
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1550,1760,24 months,20,1.1363636364
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1550,1760,36 months,28,1.5909090909
Marketscan,DMARD,Lung disease,Restrictive lung disease ,1550,1760,AS cohort entry to exposure,16,0.9090909091
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1550,1760,12 months,2,0.1136363636
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1550,1760,24 months,2,0.1136363636
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1550,1760,36 months,3,0.1704545455
Marketscan,DMARD,Neurological Disease,Spinal Cord compression,1550,1760,AS cohort entry to exposure,2,0.1136363636
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1550,1760,12 months,12,0.6818181818
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1550,1760,24 months,16,0.9090909091
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1550,1760,36 months,18,1.0227272727
Marketscan,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1550,1760,AS cohort entry to exposure,7,0.3977272727
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1550,1760,12 months,16,0.9090909091
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1550,1760,24 months,30,1.7045454545
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1550,1760,36 months,35,1.9886363636
Marketscan,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1550,1760,AS cohort entry to exposure,16,0.9090909091
Marketscan,DMARD,PsO/PsA,Psoriasis,1550,1760,12 months,81,4.6022727273
Marketscan,DMARD,PsO/PsA,Psoriasis,1550,1760,24 months,95,5.3977272727
Marketscan,DMARD,PsO/PsA,Psoriasis,1550,1760,36 months,102,5.7954545455
Marketscan,DMARD,PsO/PsA,Psoriasis,1550,1760,AS cohort entry to exposure,71,4.0340909091
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1550,1760,12 months,142,8.0681818182
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1550,1760,24 months,168,9.5454545455
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1550,1760,36 months,175,9.9431818182
Marketscan,DMARD,PsO/PsA,Psoriatic arthritis,1550,1760,AS cohort entry to exposure,96,5.4545454545
Marketscan,DMARD,Uveitis,Uveitis,1550,1760,12 months,93,5.2840909091
Marketscan,DMARD,Uveitis,Uveitis,1550,1760,24 months,109,6.1931818182
Marketscan,DMARD,Uveitis,Uveitis,1550,1760,36 months,115,6.5340909091
Marketscan,DMARD,Uveitis,Uveitis,1550,1760,AS cohort entry to exposure,64,3.6363636364
Marketscan,NSAID,Cancer,Hematologic Cancer,2700,3710,12 months,18,0.4851752022
Marketscan,NSAID,Cancer,Hematologic Cancer,2700,3710,24 months,22,0.5929919137
Marketscan,NSAID,Cancer,Hematologic Cancer,2700,3710,36 months,22,0.5929919137
Marketscan,NSAID,Cancer,Hematologic Cancer,2700,3710,AS cohort entry to exposure,18,0.4851752022
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,2700,3710,12 months,25,0.6738544474
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,2700,3710,24 months,42,1.1320754717
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,2700,3710,36 months,46,1.2398921833
Marketscan,NSAID,Cancer,Non Melanoma Skin Cancer,2700,3710,AS cohort entry to exposure,34,0.9164420485
Marketscan,NSAID,Cancer,Solid Cancer,2700,3710,12 months,139,3.7466307278
Marketscan,NSAID,Cancer,Solid Cancer,2700,3710,24 months,177,4.7708894879
Marketscan,NSAID,Cancer,Solid Cancer,2700,3710,36 months,185,4.9865229111
Marketscan,NSAID,Cancer,Solid Cancer,2700,3710,AS cohort entry to exposure,138,3.7196765499
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2700,3710,12 months,37,0.9973045822
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2700,3710,24 months,47,1.2668463612
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2700,3710,36 months,47,1.2668463612
Marketscan,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,2700,3710,AS cohort entry to exposure,35,0.9433962264
Marketscan,NSAID,Cardiac disease,Conduction Block,2700,3710,12 months,42,1.1320754717
Marketscan,NSAID,Cardiac disease,Conduction Block,2700,3710,24 months,55,1.4824797844
Marketscan,NSAID,Cardiac disease,Conduction Block,2700,3710,36 months,61,1.6442048518
Marketscan,NSAID,Cardiac disease,Conduction Block,2700,3710,AS cohort entry to exposure,34,0.9164420485
Marketscan,NSAID,Cardiac disease,Myocardial infarction,2700,3710,12 months,5,0.1347708895
Marketscan,NSAID,Cardiac disease,Myocardial infarction,2700,3710,24 months,9,0.2425876011
Marketscan,NSAID,Cardiac disease,Myocardial infarction,2700,3710,36 months,11,0.2964959569
Marketscan,NSAID,Cardiac disease,Myocardial infarction,2700,3710,AS cohort entry to exposure,6,0.1617250674
Marketscan,NSAID,Infection,Hospitalized infection,2700,3710,12 months,107,2.884097035
Marketscan,NSAID,Infection,Hospitalized infection,2700,3710,24 months,157,4.2318059299
Marketscan,NSAID,Infection,Hospitalized infection,2700,3710,36 months,185,4.9865229111
Marketscan,NSAID,Infection,Hospitalized infection,2700,3710,AS cohort entry to exposure,121,3.2614555256
Marketscan,NSAID,Infection,Opportunistic infection,2700,3710,12 months,26,0.7008086253
Marketscan,NSAID,Infection,Opportunistic infection,2700,3710,24 months,38,1.0242587601
Marketscan,NSAID,Infection,Opportunistic infection,2700,3710,36 months,44,1.1859838275
Marketscan,NSAID,Infection,Opportunistic infection,2700,3710,AS cohort entry to exposure,28,0.7547169811
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,2700,3710,12 months,81,2.1832884097
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,2700,3710,24 months,94,2.5336927224
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,2700,3710,36 months,100,2.6954177898
Marketscan,NSAID,Inflammatory bowel disease,Crohn’s Disease,2700,3710,AS cohort entry to exposure,79,2.1293800539
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2700,3710,12 months,59,1.590296496
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2700,3710,24 months,70,1.8867924528
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2700,3710,36 months,75,2.0215633423
Marketscan,NSAID,Inflammatory bowel disease,Ulcerative Colitis,2700,3710,AS cohort entry to exposure,48,1.2938005391
Marketscan,NSAID,Kidney disease,Amyloidosis,2700,3710,12 months,0,0
Marketscan,NSAID,Kidney disease,Amyloidosis,2700,3710,24 months,1,0.0269541779
Marketscan,NSAID,Kidney disease,Amyloidosis,2700,3710,36 months,1,0.0269541779
Marketscan,NSAID,Kidney disease,Amyloidosis,2700,3710,AS cohort entry to exposure,0,0
Marketscan,NSAID,Kidney disease,IgA nephropathy,2700,3710,12 months,2,0.0539083558
Marketscan,NSAID,Kidney disease,IgA nephropathy,2700,3710,24 months,3,0.0808625337
Marketscan,NSAID,Kidney disease,IgA nephropathy,2700,3710,36 months,4,0.1078167116
Marketscan,NSAID,Kidney disease,IgA nephropathy,2700,3710,AS cohort entry to exposure,0,0
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,2700,3710,12 months,0,0
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,2700,3710,24 months,1,0.0269541779
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,2700,3710,36 months,2,0.0539083558
Marketscan,NSAID,Kidney disease,Nephrotic syndrome,2700,3710,AS cohort entry to exposure,0,0
Marketscan,NSAID,Lung disease,Interstitial lung disease,2700,3710,12 months,1,0.0269541779
Marketscan,NSAID,Lung disease,Interstitial lung disease,2700,3710,24 months,2,0.0539083558
Marketscan,NSAID,Lung disease,Interstitial lung disease,2700,3710,36 months,2,0.0539083558
Marketscan,NSAID,Lung disease,Interstitial lung disease,2700,3710,AS cohort entry to exposure,2,0.0539083558
Marketscan,NSAID,Lung disease,Restrictive lung disease ,2700,3710,12 months,24,0.6469002695
Marketscan,NSAID,Lung disease,Restrictive lung disease ,2700,3710,24 months,30,0.8086253369
Marketscan,NSAID,Lung disease,Restrictive lung disease ,2700,3710,36 months,36,0.9703504043
Marketscan,NSAID,Lung disease,Restrictive lung disease ,2700,3710,AS cohort entry to exposure,38,1.0242587601
Marketscan,NSAID,Neurological Disease,Cauda Equina syndrome,2700,3710,12 months,2,0.0539083558
Marketscan,NSAID,Neurological Disease,Cauda Equina syndrome,2700,3710,24 months,2,0.0539083558
Marketscan,NSAID,Neurological Disease,Cauda Equina syndrome,2700,3710,36 months,2,0.0539083558
Marketscan,NSAID,Neurological Disease,Cauda Equina syndrome,2700,3710,AS cohort entry to exposure,0,0
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,2700,3710,12 months,13,0.3504043127
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,2700,3710,24 months,20,0.539083558
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,2700,3710,36 months,21,0.5660377358
Marketscan,NSAID,Neurological Disease,Spinal Cord compression,2700,3710,AS cohort entry to exposure,11,0.2964959569
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2700,3710,12 months,40,1.0781671159
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2700,3710,24 months,49,1.320754717
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2700,3710,36 months,52,1.4016172507
Marketscan,NSAID,Osteoporotic fracture,Clinical vertebral fracture,2700,3710,AS cohort entry to exposure,23,0.6199460916
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2700,3710,12 months,54,1.4555256065
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2700,3710,24 months,74,1.9946091644
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2700,3710,36 months,85,2.2911051213
Marketscan,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,2700,3710,AS cohort entry to exposure,55,1.4824797844
Marketscan,NSAID,PsO/PsA,Psoriasis,2700,3710,12 months,92,2.4797843666
Marketscan,NSAID,PsO/PsA,Psoriasis,2700,3710,24 months,118,3.1805929919
Marketscan,NSAID,PsO/PsA,Psoriasis,2700,3710,36 months,132,3.5579514825
Marketscan,NSAID,PsO/PsA,Psoriasis,2700,3710,AS cohort entry to exposure,85,2.2911051213
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,2700,3710,12 months,115,3.0997304582
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,2700,3710,24 months,131,3.5309973046
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,2700,3710,36 months,141,3.8005390836
Marketscan,NSAID,PsO/PsA,Psoriatic arthritis,2700,3710,AS cohort entry to exposure,125,3.3692722372
Marketscan,NSAID,Uveitis,Uveitis,2700,3710,12 months,174,4.6900269542
Marketscan,NSAID,Uveitis,Uveitis,2700,3710,24 months,217,5.8490566038
Marketscan,NSAID,Uveitis,Uveitis,2700,3710,36 months,229,6.1725067385
Marketscan,NSAID,Uveitis,Uveitis,2700,3710,AS cohort entry to exposure,158,4.2587601078
Marketscan,No exposure,Cancer,Hematologic Cancer,3368,3368,12 months,23,0.6828978622
Marketscan,No exposure,Cancer,Hematologic Cancer,3368,3368,24 months,25,0.742280285
Marketscan,No exposure,Cancer,Hematologic Cancer,3368,3368,36 months,28,0.8313539192
Marketscan,No exposure,Cancer,Hematologic Cancer,3368,3368,AS cohort entry to exposure,1,0.0296912114
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,3368,3368,12 months,25,0.742280285
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,3368,3368,24 months,42,1.2470308789
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,3368,3368,36 months,49,1.4548693587
Marketscan,No exposure,Cancer,Non Melanoma Skin Cancer,3368,3368,AS cohort entry to exposure,1,0.0296912114
Marketscan,No exposure,Cancer,Solid Cancer,3368,3368,12 months,110,3.2660332542
Marketscan,No exposure,Cancer,Solid Cancer,3368,3368,24 months,143,4.2458432304
Marketscan,No exposure,Cancer,Solid Cancer,3368,3368,36 months,161,4.7802850356
Marketscan,No exposure,Cancer,Solid Cancer,3368,3368,AS cohort entry to exposure,6,0.1781472684
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3368,3368,12 months,47,1.3954869359
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3368,3368,24 months,58,1.7220902613
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3368,3368,36 months,63,1.8705463183
Marketscan,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3368,3368,AS cohort entry to exposure,4,0.1187648456
Marketscan,No exposure,Cardiac disease,Conduction Block,3368,3368,12 months,40,1.1876484561
Marketscan,No exposure,Cardiac disease,Conduction Block,3368,3368,24 months,61,1.8111638955
Marketscan,No exposure,Cardiac disease,Conduction Block,3368,3368,36 months,69,2.0486935867
Marketscan,No exposure,Cardiac disease,Conduction Block,3368,3368,AS cohort entry to exposure,0,0
Marketscan,No exposure,Cardiac disease,Myocardial infarction,3368,3368,12 months,5,0.148456057
Marketscan,No exposure,Cardiac disease,Myocardial infarction,3368,3368,24 months,14,0.4156769596
Marketscan,No exposure,Cardiac disease,Myocardial infarction,3368,3368,36 months,16,0.4750593824
Marketscan,No exposure,Cardiac disease,Myocardial infarction,3368,3368,AS cohort entry to exposure,0,0
Marketscan,No exposure,Infection,Hospitalized infection,3368,3368,12 months,98,2.9097387173
Marketscan,No exposure,Infection,Hospitalized infection,3368,3368,24 months,155,4.6021377672
Marketscan,No exposure,Infection,Hospitalized infection,3368,3368,36 months,186,5.5225653207
Marketscan,No exposure,Infection,Hospitalized infection,3368,3368,AS cohort entry to exposure,1,0.0296912114
Marketscan,No exposure,Infection,Opportunistic infection,3368,3368,12 months,27,0.8016627078
Marketscan,No exposure,Infection,Opportunistic infection,3368,3368,24 months,36,1.0688836105
Marketscan,No exposure,Infection,Opportunistic infection,3368,3368,36 months,46,1.3657957245
Marketscan,No exposure,Infection,Opportunistic infection,3368,3368,AS cohort entry to exposure,2,0.0593824228
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,3368,3368,12 months,109,3.2363420428
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,3368,3368,24 months,131,3.8895486936
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,3368,3368,36 months,139,4.1270783848
Marketscan,No exposure,Inflammatory bowel disease,Crohn’s Disease,3368,3368,AS cohort entry to exposure,36,1.0688836105
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,3368,3368,12 months,110,3.2660332542
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,3368,3368,24 months,130,3.8598574822
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,3368,3368,36 months,135,4.0083135392
Marketscan,No exposure,Inflammatory bowel disease,Ulcerative Colitis,3368,3368,AS cohort entry to exposure,18,0.5344418052
Marketscan,No exposure,Kidney disease,Amyloidosis,3368,3368,12 months,1,0.0296912114
Marketscan,No exposure,Kidney disease,Amyloidosis,3368,3368,24 months,2,0.0593824228
Marketscan,No exposure,Kidney disease,Amyloidosis,3368,3368,36 months,2,0.0593824228
Marketscan,No exposure,Kidney disease,Amyloidosis,3368,3368,AS cohort entry to exposure,0,0
Marketscan,No exposure,Kidney disease,IgA nephropathy,3368,3368,12 months,4,0.1187648456
Marketscan,No exposure,Kidney disease,IgA nephropathy,3368,3368,24 months,5,0.148456057
Marketscan,No exposure,Kidney disease,IgA nephropathy,3368,3368,36 months,6,0.1781472684
Marketscan,No exposure,Kidney disease,IgA nephropathy,3368,3368,AS cohort entry to exposure,0,0
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,3368,3368,12 months,2,0.0593824228
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,3368,3368,24 months,2,0.0593824228
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,3368,3368,36 months,2,0.0593824228
Marketscan,No exposure,Kidney disease,Nephrotic syndrome,3368,3368,AS cohort entry to exposure,0,0
Marketscan,No exposure,Lung disease,Interstitial lung disease,3368,3368,12 months,5,0.148456057
Marketscan,No exposure,Lung disease,Interstitial lung disease,3368,3368,24 months,5,0.148456057
Marketscan,No exposure,Lung disease,Interstitial lung disease,3368,3368,36 months,6,0.1781472684
Marketscan,No exposure,Lung disease,Interstitial lung disease,3368,3368,AS cohort entry to exposure,0,0
Marketscan,No exposure,Lung disease,Restrictive lung disease ,3368,3368,12 months,35,1.039192399
Marketscan,No exposure,Lung disease,Restrictive lung disease ,3368,3368,24 months,49,1.4548693587
Marketscan,No exposure,Lung disease,Restrictive lung disease ,3368,3368,36 months,57,1.6923990499
Marketscan,No exposure,Lung disease,Restrictive lung disease ,3368,3368,AS cohort entry to exposure,0,0
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,3368,3368,12 months,2,0.0593824228
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,3368,3368,24 months,4,0.1187648456
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,3368,3368,36 months,4,0.1187648456
Marketscan,No exposure,Neurological Disease,Cauda Equina syndrome,3368,3368,AS cohort entry to exposure,1,0.0296912114
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,3368,3368,12 months,2,0.0593824228
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,3368,3368,24 months,5,0.148456057
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,3368,3368,36 months,6,0.1781472684
Marketscan,No exposure,Neurological Disease,Spinal Cord compression,3368,3368,AS cohort entry to exposure,0,0
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,3368,3368,12 months,30,0.890736342
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,3368,3368,24 months,54,1.6033254157
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,3368,3368,36 months,61,1.8111638955
Marketscan,No exposure,Osteoporotic fracture,Clinical vertebral fracture,3368,3368,AS cohort entry to exposure,3,0.0890736342
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3368,3368,12 months,35,1.039192399
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3368,3368,24 months,61,1.8111638955
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3368,3368,36 months,75,2.2268408551
Marketscan,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3368,3368,AS cohort entry to exposure,0,0
Marketscan,No exposure,PsO/PsA,Psoriasis,3368,3368,12 months,93,2.7612826603
Marketscan,No exposure,PsO/PsA,Psoriasis,3368,3368,24 months,107,3.17695962
Marketscan,No exposure,PsO/PsA,Psoriasis,3368,3368,36 months,113,3.3551068884
Marketscan,No exposure,PsO/PsA,Psoriasis,3368,3368,AS cohort entry to exposure,24,0.7125890736
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,3368,3368,12 months,120,3.5629453682
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,3368,3368,24 months,140,4.1567695962
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,3368,3368,36 months,156,4.6318289786
Marketscan,No exposure,PsO/PsA,Psoriatic arthritis,3368,3368,AS cohort entry to exposure,44,1.3064133017
Marketscan,No exposure,Uveitis,Uveitis,3368,3368,12 months,231,6.8586698337
Marketscan,No exposure,Uveitis,Uveitis,3368,3368,24 months,270,8.0166270784
Marketscan,No exposure,Uveitis,Uveitis,3368,3368,36 months,284,8.432304038
Marketscan,No exposure,Uveitis,Uveitis,3368,3368,AS cohort entry to exposure,57,1.6923990499
Marketscan,TNF,Cancer,Hematologic Cancer,3936,4768,12 months,4,0.0838926174
Marketscan,TNF,Cancer,Hematologic Cancer,3936,4768,24 months,11,0.230704698
Marketscan,TNF,Cancer,Hematologic Cancer,3936,4768,36 months,12,0.2516778523
Marketscan,TNF,Cancer,Hematologic Cancer,3936,4768,AS cohort entry to exposure,5,0.1048657718
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,3936,4768,12 months,22,0.461409396
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,3936,4768,24 months,46,0.9647651007
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,3936,4768,36 months,56,1.1744966443
Marketscan,TNF,Cancer,Non Melanoma Skin Cancer,3936,4768,AS cohort entry to exposure,27,0.5662751678
Marketscan,TNF,Cancer,Solid Cancer,3936,4768,12 months,90,1.8875838926
Marketscan,TNF,Cancer,Solid Cancer,3936,4768,24 months,122,2.5587248322
Marketscan,TNF,Cancer,Solid Cancer,3936,4768,36 months,134,2.8104026846
Marketscan,TNF,Cancer,Solid Cancer,3936,4768,AS cohort entry to exposure,64,1.3422818792
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3936,4768,12 months,40,0.8389261745
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3936,4768,24 months,49,1.0276845638
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3936,4768,36 months,57,1.1954697987
Marketscan,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,3936,4768,AS cohort entry to exposure,32,0.6711409396
Marketscan,TNF,Cardiac disease,Conduction Block,3936,4768,12 months,26,0.5453020134
Marketscan,TNF,Cardiac disease,Conduction Block,3936,4768,24 months,40,0.8389261745
Marketscan,TNF,Cardiac disease,Conduction Block,3936,4768,36 months,49,1.0276845638
Marketscan,TNF,Cardiac disease,Conduction Block,3936,4768,AS cohort entry to exposure,22,0.461409396
Marketscan,TNF,Cardiac disease,Myocardial infarction,3936,4768,12 months,6,0.1258389262
Marketscan,TNF,Cardiac disease,Myocardial infarction,3936,4768,24 months,16,0.3355704698
Marketscan,TNF,Cardiac disease,Myocardial infarction,3936,4768,36 months,19,0.3984899329
Marketscan,TNF,Cardiac disease,Myocardial infarction,3936,4768,AS cohort entry to exposure,8,0.1677852349
Marketscan,TNF,Infection,Hospitalized infection,3936,4768,12 months,149,3.125
Marketscan,TNF,Infection,Hospitalized infection,3936,4768,24 months,219,4.5931208054
Marketscan,TNF,Infection,Hospitalized infection,3936,4768,36 months,249,5.2223154362
Marketscan,TNF,Infection,Hospitalized infection,3936,4768,AS cohort entry to exposure,126,2.6426174497
Marketscan,TNF,Infection,Opportunistic infection,3936,4768,12 months,46,0.9647651007
Marketscan,TNF,Infection,Opportunistic infection,3936,4768,24 months,61,1.2793624161
Marketscan,TNF,Infection,Opportunistic infection,3936,4768,36 months,70,1.4681208054
Marketscan,TNF,Infection,Opportunistic infection,3936,4768,AS cohort entry to exposure,42,0.8808724832
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,3936,4768,12 months,271,5.6837248322
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,3936,4768,24 months,301,6.3129194631
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,3936,4768,36 months,310,6.5016778523
Marketscan,TNF,Inflammatory bowel disease,Crohn’s Disease,3936,4768,AS cohort entry to exposure,226,4.7399328859
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,3936,4768,12 months,183,3.8380872483
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,3936,4768,24 months,208,4.3624161074
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,3936,4768,36 months,221,4.6350671141
Marketscan,TNF,Inflammatory bowel disease,Ulcerative Colitis,3936,4768,AS cohort entry to exposure,139,2.9152684564
Marketscan,TNF,Kidney disease,Amyloidosis,3936,4768,12 months,1,0.0209731544
Marketscan,TNF,Kidney disease,Amyloidosis,3936,4768,24 months,3,0.0629194631
Marketscan,TNF,Kidney disease,Amyloidosis,3936,4768,36 months,3,0.0629194631
Marketscan,TNF,Kidney disease,Amyloidosis,3936,4768,AS cohort entry to exposure,0,0
Marketscan,TNF,Kidney disease,IgA nephropathy,3936,4768,12 months,5,0.1048657718
Marketscan,TNF,Kidney disease,IgA nephropathy,3936,4768,24 months,7,0.1468120805
Marketscan,TNF,Kidney disease,IgA nephropathy,3936,4768,36 months,8,0.1677852349
Marketscan,TNF,Kidney disease,IgA nephropathy,3936,4768,AS cohort entry to exposure,5,0.1048657718
Marketscan,TNF,Kidney disease,Nephrotic syndrome,3936,4768,12 months,3,0.0629194631
Marketscan,TNF,Kidney disease,Nephrotic syndrome,3936,4768,24 months,5,0.1048657718
Marketscan,TNF,Kidney disease,Nephrotic syndrome,3936,4768,36 months,5,0.1048657718
Marketscan,TNF,Kidney disease,Nephrotic syndrome,3936,4768,AS cohort entry to exposure,2,0.0419463087
Marketscan,TNF,Lung disease,Interstitial lung disease,3936,4768,12 months,6,0.1258389262
Marketscan,TNF,Lung disease,Interstitial lung disease,3936,4768,24 months,7,0.1468120805
Marketscan,TNF,Lung disease,Interstitial lung disease,3936,4768,36 months,7,0.1468120805
Marketscan,TNF,Lung disease,Interstitial lung disease,3936,4768,AS cohort entry to exposure,3,0.0629194631
Marketscan,TNF,Lung disease,Restrictive lung disease ,3936,4768,12 months,36,0.755033557
Marketscan,TNF,Lung disease,Restrictive lung disease ,3936,4768,24 months,56,1.1744966443
Marketscan,TNF,Lung disease,Restrictive lung disease ,3936,4768,36 months,62,1.3003355705
Marketscan,TNF,Lung disease,Restrictive lung disease ,3936,4768,AS cohort entry to exposure,27,0.5662751678
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,3936,4768,12 months,0,0
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,3936,4768,24 months,1,0.0209731544
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,3936,4768,36 months,1,0.0209731544
Marketscan,TNF,Neurological Disease,Cauda Equina syndrome,3936,4768,AS cohort entry to exposure,0,0
Marketscan,TNF,Neurological Disease,Spinal Cord compression,3936,4768,12 months,7,0.1468120805
Marketscan,TNF,Neurological Disease,Spinal Cord compression,3936,4768,24 months,14,0.2936241611
Marketscan,TNF,Neurological Disease,Spinal Cord compression,3936,4768,36 months,20,0.4194630872
Marketscan,TNF,Neurological Disease,Spinal Cord compression,3936,4768,AS cohort entry to exposure,5,0.1048657718
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,3936,4768,12 months,23,0.4823825503
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,3936,4768,24 months,36,0.755033557
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,3936,4768,36 months,38,0.7969798658
Marketscan,TNF,Osteoporotic fracture,Clinical vertebral fracture,3936,4768,AS cohort entry to exposure,10,0.2097315436
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3936,4768,12 months,36,0.755033557
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3936,4768,24 months,74,1.5520134228
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3936,4768,36 months,87,1.8246644295
Marketscan,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,3936,4768,AS cohort entry to exposure,35,0.7340604027
Marketscan,TNF,PsO/PsA,Psoriasis,3936,4768,12 months,236,4.9496644295
Marketscan,TNF,PsO/PsA,Psoriasis,3936,4768,24 months,297,6.2290268456
Marketscan,TNF,PsO/PsA,Psoriasis,3936,4768,36 months,330,6.9211409396
Marketscan,TNF,PsO/PsA,Psoriasis,3936,4768,AS cohort entry to exposure,184,3.8590604027
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,3936,4768,12 months,415,8.7038590604
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,3936,4768,24 months,482,10.109060403
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,3936,4768,36 months,502,10.52852349
Marketscan,TNF,PsO/PsA,Psoriatic arthritis,3936,4768,AS cohort entry to exposure,344,7.2147651007
Marketscan,TNF,Uveitis,Uveitis,3936,4768,12 months,332,6.9630872483
Marketscan,TNF,Uveitis,Uveitis,3936,4768,24 months,399,8.3682885906
Marketscan,TNF,Uveitis,Uveitis,3936,4768,36 months,429,8.9974832215
Marketscan,TNF,Uveitis,Uveitis,3936,4768,AS cohort entry to exposure,269,5.6417785235
Medicare,DMARD,Cancer,Hematologic Cancer,1599,1939,12 months,34,1.7534811759
Medicare,DMARD,Cancer,Hematologic Cancer,1599,1939,24 months,47,2.4239298608
Medicare,DMARD,Cancer,Hematologic Cancer,1599,1939,36 months,49,2.5270758123
Medicare,DMARD,Cancer,Hematologic Cancer,1599,1939,AS cohort entry to exposure,31,1.5987622486
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1599,1939,12 months,44,2.2692109335
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1599,1939,24 months,68,3.5069623517
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1599,1939,36 months,102,5.2604435276
Medicare,DMARD,Cancer,Non Melanoma Skin Cancer,1599,1939,AS cohort entry to exposure,42,2.1660649819
Medicare,DMARD,Cancer,Solid Cancer,1599,1939,12 months,222,11.449200619
Medicare,DMARD,Cancer,Solid Cancer,1599,1939,24 months,280,14.440433213
Medicare,DMARD,Cancer,Solid Cancer,1599,1939,36 months,310,15.987622486
Medicare,DMARD,Cancer,Solid Cancer,1599,1939,AS cohort entry to exposure,223,11.500773595
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1599,1939,12 months,106,5.4667354306
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1599,1939,24 months,157,8.0969571944
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1599,1939,36 months,182,9.3862815884
Medicare,DMARD,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1599,1939,AS cohort entry to exposure,120,6.1887570913
Medicare,DMARD,Cardiac disease,Conduction Block,1599,1939,12 months,83,4.2805569881
Medicare,DMARD,Cardiac disease,Conduction Block,1599,1939,24 months,129,6.6529138731
Medicare,DMARD,Cardiac disease,Conduction Block,1599,1939,36 months,166,8.5611139763
Medicare,DMARD,Cardiac disease,Conduction Block,1599,1939,AS cohort entry to exposure,81,4.1774110366
Medicare,DMARD,Cardiac disease,Myocardial infarction,1599,1939,12 months,28,1.4440433213
Medicare,DMARD,Cardiac disease,Myocardial infarction,1599,1939,24 months,56,2.8880866426
Medicare,DMARD,Cardiac disease,Myocardial infarction,1599,1939,36 months,69,3.5585353275
Medicare,DMARD,Cardiac disease,Myocardial infarction,1599,1939,AS cohort entry to exposure,31,1.5987622486
Medicare,DMARD,Infection,Hospitalized infection,1599,1939,12 months,259,13.357400722
Medicare,DMARD,Infection,Hospitalized infection,1599,1939,24 months,410,21.144920062
Medicare,DMARD,Infection,Hospitalized infection,1599,1939,36 months,519,26.76637442
Medicare,DMARD,Infection,Hospitalized infection,1599,1939,AS cohort entry to exposure,309,15.93604951
Medicare,DMARD,Infection,Opportunistic infection,1599,1939,12 months,50,2.578648788
Medicare,DMARD,Infection,Opportunistic infection,1599,1939,24 months,81,4.1774110366
Medicare,DMARD,Infection,Opportunistic infection,1599,1939,36 months,97,5.0025786488
Medicare,DMARD,Infection,Opportunistic infection,1599,1939,AS cohort entry to exposure,64,3.3006704487
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1599,1939,12 months,49,2.5270758123
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1599,1939,24 months,57,2.9396596184
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1599,1939,36 months,63,3.2490974729
Medicare,DMARD,Inflammatory bowel disease,Crohn’s Disease,1599,1939,AS cohort entry to exposure,46,2.372356885
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1599,1939,12 months,57,2.9396596184
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1599,1939,24 months,77,3.9711191336
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1599,1939,36 months,81,4.1774110366
Medicare,DMARD,Inflammatory bowel disease,Ulcerative Colitis,1599,1939,AS cohort entry to exposure,66,3.4038164002
Medicare,DMARD,Kidney disease,Amyloidosis,1599,1939,12 months,2,0.1031459515
Medicare,DMARD,Kidney disease,Amyloidosis,1599,1939,24 months,2,0.1031459515
Medicare,DMARD,Kidney disease,Amyloidosis,1599,1939,36 months,2,0.1031459515
Medicare,DMARD,Kidney disease,Amyloidosis,1599,1939,AS cohort entry to exposure,2,0.1031459515
Medicare,DMARD,Kidney disease,IgA nephropathy,1599,1939,12 months,1,0.0515729758
Medicare,DMARD,Kidney disease,IgA nephropathy,1599,1939,24 months,3,0.1547189273
Medicare,DMARD,Kidney disease,IgA nephropathy,1599,1939,36 months,5,0.2578648788
Medicare,DMARD,Kidney disease,IgA nephropathy,1599,1939,AS cohort entry to exposure,5,0.2578648788
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1599,1939,12 months,5,0.2578648788
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1599,1939,24 months,6,0.3094378546
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1599,1939,36 months,6,0.3094378546
Medicare,DMARD,Kidney disease,Nephrotic syndrome,1599,1939,AS cohort entry to exposure,3,0.1547189273
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1599,1939,12 months,0,0
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1599,1939,24 months,1,0.0515729758
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1599,1939,36 months,2,0.1031459515
Medicare,DMARD,Lung disease,Apical Pulmonary fibrosis,1599,1939,AS cohort entry to exposure,1,0.0515729758
Medicare,DMARD,Lung disease,Interstitial lung disease,1599,1939,12 months,23,1.1861784425
Medicare,DMARD,Lung disease,Interstitial lung disease,1599,1939,24 months,31,1.5987622486
Medicare,DMARD,Lung disease,Interstitial lung disease,1599,1939,36 months,41,2.1144920062
Medicare,DMARD,Lung disease,Interstitial lung disease,1599,1939,AS cohort entry to exposure,26,1.3408973698
Medicare,DMARD,Lung disease,Restrictive lung disease ,1599,1939,12 months,74,3.8164002063
Medicare,DMARD,Lung disease,Restrictive lung disease ,1599,1939,24 months,110,5.6730273337
Medicare,DMARD,Lung disease,Restrictive lung disease ,1599,1939,36 months,141,7.2717895823
Medicare,DMARD,Lung disease,Restrictive lung disease ,1599,1939,AS cohort entry to exposure,96,4.951005673
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1599,1939,12 months,2,0.1031459515
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1599,1939,24 months,4,0.206291903
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1599,1939,36 months,5,0.2578648788
Medicare,DMARD,Neurological Disease,Cauda Equina syndrome,1599,1939,AS cohort entry to exposure,1,0.0515729758
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1599,1939,12 months,2,0.1031459515
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1599,1939,24 months,5,0.2578648788
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1599,1939,36 months,7,0.3610108303
Medicare,DMARD,Neurological Disease,Spinal Cord compression,1599,1939,AS cohort entry to exposure,3,0.1547189273
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1599,1939,12 months,68,3.5069623517
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1599,1939,24 months,113,5.827746261
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1599,1939,36 months,150,7.7359463641
Medicare,DMARD,Osteoporotic fracture,Clinical vertebral fracture,1599,1939,AS cohort entry to exposure,106,5.4667354306
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1599,1939,12 months,78,4.0226921093
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1599,1939,24 months,137,7.0654976792
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1599,1939,36 months,176,9.0768437339
Medicare,DMARD,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1599,1939,AS cohort entry to exposure,110,5.6730273337
Medicare,DMARD,PsO/PsA,Psoriasis,1599,1939,12 months,76,3.9195461578
Medicare,DMARD,PsO/PsA,Psoriasis,1599,1939,24 months,104,5.3635894791
Medicare,DMARD,PsO/PsA,Psoriasis,1599,1939,36 months,124,6.3950489943
Medicare,DMARD,PsO/PsA,Psoriasis,1599,1939,AS cohort entry to exposure,91,4.6931407942
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1599,1939,12 months,121,6.240330067
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1599,1939,24 months,142,7.323362558
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1599,1939,36 months,156,8.0453842187
Medicare,DMARD,PsO/PsA,Psoriatic arthritis,1599,1939,AS cohort entry to exposure,121,6.240330067
Medicare,DMARD,Uveitis,Uveitis,1599,1939,12 months,55,2.8365136668
Medicare,DMARD,Uveitis,Uveitis,1599,1939,24 months,61,3.1459515214
Medicare,DMARD,Uveitis,Uveitis,1599,1939,36 months,69,3.5585353275
Medicare,DMARD,Uveitis,Uveitis,1599,1939,AS cohort entry to exposure,53,2.7333677153
Medicare,NSAID,Cancer,Hematologic Cancer,4448,7034,12 months,117,1.6633494456
Medicare,NSAID,Cancer,Hematologic Cancer,4448,7034,24 months,143,2.0329826557
Medicare,NSAID,Cancer,Hematologic Cancer,4448,7034,36 months,158,2.2462325846
Medicare,NSAID,Cancer,Hematologic Cancer,4448,7034,AS cohort entry to exposure,135,1.9192493603
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,4448,7034,12 months,170,2.4168325277
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,4448,7034,24 months,285,4.0517486494
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,4448,7034,36 months,369,5.2459482514
Medicare,NSAID,Cancer,Non Melanoma Skin Cancer,4448,7034,AS cohort entry to exposure,192,2.7295990901
Medicare,NSAID,Cancer,Solid Cancer,4448,7034,12 months,913,12.97981234
Medicare,NSAID,Cancer,Solid Cancer,4448,7034,24 months,1106,15.723628092
Medicare,NSAID,Cancer,Solid Cancer,4448,7034,36 months,1214,17.25902758
Medicare,NSAID,Cancer,Solid Cancer,4448,7034,AS cohort entry to exposure,1048,14.8990617
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4448,7034,12 months,459,6.5254478249
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4448,7034,24 months,643,9.1413136196
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4448,7034,36 months,769,10.932613022
Medicare,NSAID,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,4448,7034,AS cohort entry to exposure,589,8.3736138755
Medicare,NSAID,Cardiac disease,Conduction Block,4448,7034,12 months,306,4.3502985499
Medicare,NSAID,Cardiac disease,Conduction Block,4448,7034,24 months,453,6.4401478533
Medicare,NSAID,Cardiac disease,Conduction Block,4448,7034,36 months,569,8.0892806369
Medicare,NSAID,Cardiac disease,Conduction Block,4448,7034,AS cohort entry to exposure,455,6.4685811771
Medicare,NSAID,Cardiac disease,Myocardial infarction,4448,7034,12 months,76,1.0804663065
Medicare,NSAID,Cardiac disease,Myocardial infarction,4448,7034,24 months,147,2.0898493034
Medicare,NSAID,Cardiac disease,Myocardial infarction,4448,7034,36 months,208,2.957065681
Medicare,NSAID,Cardiac disease,Myocardial infarction,4448,7034,AS cohort entry to exposure,134,1.9050326983
Medicare,NSAID,Infection,Hospitalized infection,4448,7034,12 months,917,13.036678988
Medicare,NSAID,Infection,Hospitalized infection,4448,7034,24 months,1439,20.457776514
Medicare,NSAID,Infection,Hospitalized infection,4448,7034,36 months,1796,25.533124822
Medicare,NSAID,Infection,Hospitalized infection,4448,7034,AS cohort entry to exposure,1323,18.80864373
Medicare,NSAID,Infection,Opportunistic infection,4448,7034,12 months,131,1.8623827125
Medicare,NSAID,Infection,Opportunistic infection,4448,7034,24 months,210,2.9854990048
Medicare,NSAID,Infection,Opportunistic infection,4448,7034,36 months,284,4.0375319875
Medicare,NSAID,Infection,Opportunistic infection,4448,7034,AS cohort entry to exposure,232,3.2982655672
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,4448,7034,12 months,70,0.9951663349
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,4448,7034,24 months,92,1.3079328974
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,4448,7034,36 months,107,1.5211828263
Medicare,NSAID,Inflammatory bowel disease,Crohn’s Disease,4448,7034,AS cohort entry to exposure,92,1.3079328974
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,4448,7034,12 months,76,1.0804663065
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,4448,7034,24 months,111,1.578049474
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,4448,7034,36 months,139,1.976116008
Medicare,NSAID,Inflammatory bowel disease,Ulcerative Colitis,4448,7034,AS cohort entry to exposure,128,1.8197327268
Medicare,NSAID,Kidney disease,Amyloidosis,4448,7034,12 months,3,0.0426499858
Medicare,NSAID,Kidney disease,Amyloidosis,4448,7034,24 months,4,0.0568666477
Medicare,NSAID,Kidney disease,Amyloidosis,4448,7034,36 months,4,0.0568666477
Medicare,NSAID,Kidney disease,Amyloidosis,4448,7034,AS cohort entry to exposure,4,0.0568666477
Medicare,NSAID,Kidney disease,IgA nephropathy,4448,7034,12 months,6,0.0852999716
Medicare,NSAID,Kidney disease,IgA nephropathy,4448,7034,24 months,8,0.1137332954
Medicare,NSAID,Kidney disease,IgA nephropathy,4448,7034,36 months,9,0.1279499574
Medicare,NSAID,Kidney disease,IgA nephropathy,4448,7034,AS cohort entry to exposure,11,0.1563832812
Medicare,NSAID,Kidney disease,Nephrotic syndrome,4448,7034,12 months,5,0.0710833096
Medicare,NSAID,Kidney disease,Nephrotic syndrome,4448,7034,24 months,7,0.0995166335
Medicare,NSAID,Kidney disease,Nephrotic syndrome,4448,7034,36 months,7,0.0995166335
Medicare,NSAID,Kidney disease,Nephrotic syndrome,4448,7034,AS cohort entry to exposure,5,0.0710833096
Medicare,NSAID,Lung disease,Interstitial lung disease,4448,7034,12 months,31,0.4407165198
Medicare,NSAID,Lung disease,Interstitial lung disease,4448,7034,24 months,36,0.5117998294
Medicare,NSAID,Lung disease,Interstitial lung disease,4448,7034,36 months,44,0.6255331248
Medicare,NSAID,Lung disease,Interstitial lung disease,4448,7034,AS cohort entry to exposure,42,0.597099801
Medicare,NSAID,Lung disease,Restrictive lung disease ,4448,7034,12 months,222,3.156098948
Medicare,NSAID,Lung disease,Restrictive lung disease ,4448,7034,24 months,332,4.71993176
Medicare,NSAID,Lung disease,Restrictive lung disease ,4448,7034,36 months,397,5.6440147853
Medicare,NSAID,Lung disease,Restrictive lung disease ,4448,7034,AS cohort entry to exposure,354,5.0326983224
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,4448,7034,12 months,5,0.0710833096
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,4448,7034,24 months,11,0.1563832812
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,4448,7034,36 months,12,0.1705999431
Medicare,NSAID,Neurological Disease,Cauda Equina syndrome,4448,7034,AS cohort entry to exposure,6,0.0852999716
Medicare,NSAID,Neurological Disease,Spinal Cord compression,4448,7034,12 months,17,0.2416832528
Medicare,NSAID,Neurological Disease,Spinal Cord compression,4448,7034,24 months,25,0.3554165482
Medicare,NSAID,Neurological Disease,Spinal Cord compression,4448,7034,36 months,40,0.5686664771
Medicare,NSAID,Neurological Disease,Spinal Cord compression,4448,7034,AS cohort entry to exposure,23,0.3269832243
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,4448,7034,12 months,339,4.8194483935
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,4448,7034,24 months,520,7.3926642024
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,4448,7034,36 months,639,9.0844469719
Medicare,NSAID,Osteoporotic fracture,Clinical vertebral fracture,4448,7034,AS cohort entry to exposure,495,7.0372476543
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4448,7034,12 months,412,5.8572647142
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4448,7034,24 months,630,8.9564970145
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4448,7034,36 months,794,11.288029571
Medicare,NSAID,Osteoporotic fracture,Non-vertebral osteoporotic fracture,4448,7034,AS cohort entry to exposure,656,9.3261302246
Medicare,NSAID,PsO/PsA,Psoriasis,4448,7034,12 months,175,2.4879158374
Medicare,NSAID,PsO/PsA,Psoriasis,4448,7034,24 months,245,3.4830821723
Medicare,NSAID,PsO/PsA,Psoriasis,4448,7034,36 months,285,4.0517486494
Medicare,NSAID,PsO/PsA,Psoriasis,4448,7034,AS cohort entry to exposure,287,4.0801819733
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,4448,7034,12 months,123,1.7486494171
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,4448,7034,24 months,150,2.1324992892
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,4448,7034,36 months,164,2.3315325562
Medicare,NSAID,PsO/PsA,Psoriatic arthritis,4448,7034,AS cohort entry to exposure,188,2.6727324424
Medicare,NSAID,Uveitis,Uveitis,4448,7034,12 months,101,1.4358828547
Medicare,NSAID,Uveitis,Uveitis,4448,7034,24 months,136,1.9334660222
Medicare,NSAID,Uveitis,Uveitis,4448,7034,36 months,152,2.160932613
Medicare,NSAID,Uveitis,Uveitis,4448,7034,AS cohort entry to exposure,155,2.2035825988
Medicare,No exposure,Cancer,Hematologic Cancer,5221,5221,12 months,80,1.5322735108
Medicare,No exposure,Cancer,Hematologic Cancer,5221,5221,24 months,101,1.9344953074
Medicare,No exposure,Cancer,Hematologic Cancer,5221,5221,36 months,120,2.2984102662
Medicare,No exposure,Cancer,Hematologic Cancer,5221,5221,AS cohort entry to exposure,2,0.0383068378
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,5221,5221,12 months,116,2.2217965907
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,5221,5221,24 months,193,3.6966098449
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,5221,5221,36 months,245,4.6925876269
Medicare,No exposure,Cancer,Non Melanoma Skin Cancer,5221,5221,AS cohort entry to exposure,1,0.0191534189
Medicare,No exposure,Cancer,Solid Cancer,5221,5221,12 months,690,13.215859031
Medicare,No exposure,Cancer,Solid Cancer,5221,5221,24 months,842,16.127178701
Medicare,No exposure,Cancer,Solid Cancer,5221,5221,36 months,957,18.329821873
Medicare,No exposure,Cancer,Solid Cancer,5221,5221,AS cohort entry to exposure,26,0.497988891
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,5221,5221,12 months,376,7.2016855009
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,5221,5221,24 months,505,9.6724765371
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,5221,5221,36 months,601,11.51120475
Medicare,No exposure,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,5221,5221,AS cohort entry to exposure,7,0.1340739322
Medicare,No exposure,Cardiac disease,Conduction Block,5221,5221,12 months,203,3.8881440337
Medicare,No exposure,Cardiac disease,Conduction Block,5221,5221,24 months,355,6.7994637043
Medicare,No exposure,Cardiac disease,Conduction Block,5221,5221,36 months,447,8.5615782417
Medicare,No exposure,Cardiac disease,Conduction Block,5221,5221,AS cohort entry to exposure,0,0
Medicare,No exposure,Cardiac disease,Myocardial infarction,5221,5221,12 months,60,1.1492051331
Medicare,No exposure,Cardiac disease,Myocardial infarction,5221,5221,24 months,129,2.4707910362
Medicare,No exposure,Cardiac disease,Myocardial infarction,5221,5221,36 months,179,3.4284619805
Medicare,No exposure,Cardiac disease,Myocardial infarction,5221,5221,AS cohort entry to exposure,0,0
Medicare,No exposure,Infection,Hospitalized infection,5221,5221,12 months,577,11.051522697
Medicare,No exposure,Infection,Hospitalized infection,5221,5221,24 months,1034,19.804635127
Medicare,No exposure,Infection,Hospitalized infection,5221,5221,36 months,1335,25.569814212
Medicare,No exposure,Infection,Hospitalized infection,5221,5221,AS cohort entry to exposure,1,0.0191534189
Medicare,No exposure,Infection,Opportunistic infection,5221,5221,12 months,82,1.5705803486
Medicare,No exposure,Infection,Opportunistic infection,5221,5221,24 months,143,2.7389389006
Medicare,No exposure,Infection,Opportunistic infection,5221,5221,36 months,178,3.4093085616
Medicare,No exposure,Infection,Opportunistic infection,5221,5221,AS cohort entry to exposure,2,0.0383068378
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,5221,5221,12 months,81,1.5514269297
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,5221,5221,24 months,102,1.9536487263
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,5221,5221,36 months,114,2.1834897529
Medicare,No exposure,Inflammatory bowel disease,Crohn’s Disease,5221,5221,AS cohort entry to exposure,14,0.2681478644
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,5221,5221,12 months,80,1.5322735108
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,5221,5221,24 months,110,2.1068760774
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,5221,5221,36 months,133,2.5474047117
Medicare,No exposure,Inflammatory bowel disease,Ulcerative Colitis,5221,5221,AS cohort entry to exposure,10,0.1915341889
Medicare,No exposure,Kidney disease,Amyloidosis,5221,5221,12 months,3,0.0574602567
Medicare,No exposure,Kidney disease,Amyloidosis,5221,5221,24 months,5,0.0957670944
Medicare,No exposure,Kidney disease,Amyloidosis,5221,5221,36 months,7,0.1340739322
Medicare,No exposure,Kidney disease,Amyloidosis,5221,5221,AS cohort entry to exposure,0,0
Medicare,No exposure,Kidney disease,IgA nephropathy,5221,5221,12 months,4,0.0766136755
Medicare,No exposure,Kidney disease,IgA nephropathy,5221,5221,24 months,9,0.17238077
Medicare,No exposure,Kidney disease,IgA nephropathy,5221,5221,36 months,10,0.1915341889
Medicare,No exposure,Kidney disease,IgA nephropathy,5221,5221,AS cohort entry to exposure,0,0
Medicare,No exposure,Kidney disease,Nephrotic syndrome,5221,5221,12 months,7,0.1340739322
Medicare,No exposure,Kidney disease,Nephrotic syndrome,5221,5221,24 months,9,0.17238077
Medicare,No exposure,Kidney disease,Nephrotic syndrome,5221,5221,36 months,10,0.1915341889
Medicare,No exposure,Kidney disease,Nephrotic syndrome,5221,5221,AS cohort entry to exposure,0,0
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,5221,5221,12 months,1,0.0191534189
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,5221,5221,24 months,1,0.0191534189
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,5221,5221,36 months,1,0.0191534189
Medicare,No exposure,Lung disease,Apical Pulmonary fibrosis,5221,5221,AS cohort entry to exposure,0,0
Medicare,No exposure,Lung disease,Interstitial lung disease,5221,5221,12 months,27,0.5171423099
Medicare,No exposure,Lung disease,Interstitial lung disease,5221,5221,24 months,41,0.7852901743
Medicare,No exposure,Lung disease,Interstitial lung disease,5221,5221,36 months,43,0.8235970121
Medicare,No exposure,Lung disease,Interstitial lung disease,5221,5221,AS cohort entry to exposure,0,0
Medicare,No exposure,Lung disease,Restrictive lung disease ,5221,5221,12 months,170,3.2560812105
Medicare,No exposure,Lung disease,Restrictive lung disease ,5221,5221,24 months,239,4.5776671136
Medicare,No exposure,Lung disease,Restrictive lung disease ,5221,5221,36 months,294,5.6311051523
Medicare,No exposure,Lung disease,Restrictive lung disease ,5221,5221,AS cohort entry to exposure,0,0
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,5221,5221,12 months,7,0.1340739322
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,5221,5221,24 months,9,0.17238077
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,5221,5221,36 months,11,0.2106876077
Medicare,No exposure,Neurological Disease,Cauda Equina syndrome,5221,5221,AS cohort entry to exposure,1,0.0191534189
Medicare,No exposure,Neurological Disease,Spinal Cord compression,5221,5221,12 months,12,0.2298410266
Medicare,No exposure,Neurological Disease,Spinal Cord compression,5221,5221,24 months,16,0.3064547022
Medicare,No exposure,Neurological Disease,Spinal Cord compression,5221,5221,36 months,21,0.4022217966
Medicare,No exposure,Neurological Disease,Spinal Cord compression,5221,5221,AS cohort entry to exposure,0,0
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,5221,5221,12 months,235,4.501053438
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,5221,5221,24 months,363,6.9526910554
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,5221,5221,36 months,467,8.9446466194
Medicare,No exposure,Osteoporotic fracture,Clinical vertebral fracture,5221,5221,AS cohort entry to exposure,15,0.2873012833
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,5221,5221,12 months,230,4.4052863436
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,5221,5221,24 months,401,7.680520973
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,5221,5221,36 months,510,9.7682436315
Medicare,No exposure,Osteoporotic fracture,Non-vertebral osteoporotic fracture,5221,5221,AS cohort entry to exposure,3,0.0574602567
Medicare,No exposure,PsO/PsA,Psoriasis,5221,5221,12 months,146,2.7963991572
Medicare,No exposure,PsO/PsA,Psoriasis,5221,5221,24 months,201,3.8498371959
Medicare,No exposure,PsO/PsA,Psoriasis,5221,5221,36 months,226,4.3286726681
Medicare,No exposure,PsO/PsA,Psoriasis,5221,5221,AS cohort entry to exposure,21,0.4022217966
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,5221,5221,12 months,120,2.2984102662
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,5221,5221,24 months,141,2.7006320628
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,5221,5221,36 months,153,2.9304730894
Medicare,No exposure,PsO/PsA,Psoriatic arthritis,5221,5221,AS cohort entry to exposure,36,0.6895230799
Medicare,No exposure,Uveitis,Uveitis,5221,5221,12 months,83,1.5897337675
Medicare,No exposure,Uveitis,Uveitis,5221,5221,24 months,112,2.1451829152
Medicare,No exposure,Uveitis,Uveitis,5221,5221,36 months,119,2.2792568473
Medicare,No exposure,Uveitis,Uveitis,5221,5221,AS cohort entry to exposure,9,0.17238077
Medicare,TNF,Cancer,Hematologic Cancer,1112,1289,12 months,8,0.6206361521
Medicare,TNF,Cancer,Hematologic Cancer,1112,1289,24 months,18,1.3964313421
Medicare,TNF,Cancer,Hematologic Cancer,1112,1289,36 months,25,1.9394879752
Medicare,TNF,Cancer,Hematologic Cancer,1112,1289,AS cohort entry to exposure,8,0.6206361521
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,1112,1289,12 months,28,2.1722265322
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,1112,1289,24 months,48,3.7238169123
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,1112,1289,36 months,67,5.1978277735
Medicare,TNF,Cancer,Non Melanoma Skin Cancer,1112,1289,AS cohort entry to exposure,25,1.9394879752
Medicare,TNF,Cancer,Solid Cancer,1112,1289,12 months,141,10.93871218
Medicare,TNF,Cancer,Solid Cancer,1112,1289,24 months,168,13.033359193
Medicare,TNF,Cancer,Solid Cancer,1112,1289,36 months,190,14.740108611
Medicare,TNF,Cancer,Solid Cancer,1112,1289,AS cohort entry to exposure,108,8.3785880528
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1112,1289,12 months,78,6.0512024825
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1112,1289,24 months,110,8.5337470908
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1112,1289,36 months,129,10.007757952
Medicare,TNF,Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,1112,1289,AS cohort entry to exposure,69,5.3529868115
Medicare,TNF,Cardiac disease,Conduction Block,1112,1289,12 months,76,5.8960434445
Medicare,TNF,Cardiac disease,Conduction Block,1112,1289,24 months,102,7.9131109387
Medicare,TNF,Cardiac disease,Conduction Block,1112,1289,36 months,125,9.6974398759
Medicare,TNF,Cardiac disease,Conduction Block,1112,1289,AS cohort entry to exposure,57,4.4220325834
Medicare,TNF,Cardiac disease,Myocardial infarction,1112,1289,12 months,17,1.3188518231
Medicare,TNF,Cardiac disease,Myocardial infarction,1112,1289,24 months,30,2.3273855702
Medicare,TNF,Cardiac disease,Myocardial infarction,1112,1289,36 months,35,2.7152831652
Medicare,TNF,Cardiac disease,Myocardial infarction,1112,1289,AS cohort entry to exposure,19,1.4740108611
Medicare,TNF,Infection,Hospitalized infection,1112,1289,12 months,132,10.240496509
Medicare,TNF,Infection,Hospitalized infection,1112,1289,24 months,240,18.619084562
Medicare,TNF,Infection,Hospitalized infection,1112,1289,36 months,293,22.730799069
Medicare,TNF,Infection,Hospitalized infection,1112,1289,AS cohort entry to exposure,135,10.473235066
Medicare,TNF,Infection,Opportunistic infection,1112,1289,12 months,47,3.6462373933
Medicare,TNF,Infection,Opportunistic infection,1112,1289,24 months,68,5.2754072925
Medicare,TNF,Infection,Opportunistic infection,1112,1289,36 months,79,6.1287820016
Medicare,TNF,Infection,Opportunistic infection,1112,1289,AS cohort entry to exposure,54,4.1892940264
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,1112,1289,12 months,72,5.5857253685
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,1112,1289,24 months,80,6.2063615206
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,1112,1289,36 months,83,6.4391000776
Medicare,TNF,Inflammatory bowel disease,Crohn’s Disease,1112,1289,AS cohort entry to exposure,68,5.2754072925
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,1112,1289,12 months,58,4.4996121024
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,1112,1289,24 months,72,5.5857253685
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,1112,1289,36 months,76,5.8960434445
Medicare,TNF,Inflammatory bowel disease,Ulcerative Colitis,1112,1289,AS cohort entry to exposure,50,3.8789759503
Medicare,TNF,Kidney disease,IgA nephropathy,1112,1289,12 months,2,0.155159038
Medicare,TNF,Kidney disease,IgA nephropathy,1112,1289,24 months,4,0.310318076
Medicare,TNF,Kidney disease,IgA nephropathy,1112,1289,36 months,6,0.465477114
Medicare,TNF,Kidney disease,IgA nephropathy,1112,1289,AS cohort entry to exposure,2,0.155159038
Medicare,TNF,Kidney disease,Nephrotic syndrome,1112,1289,12 months,1,0.077579519
Medicare,TNF,Kidney disease,Nephrotic syndrome,1112,1289,24 months,1,0.077579519
Medicare,TNF,Kidney disease,Nephrotic syndrome,1112,1289,36 months,1,0.077579519
Medicare,TNF,Kidney disease,Nephrotic syndrome,1112,1289,AS cohort entry to exposure,0,0
Medicare,TNF,Lung disease,Interstitial lung disease,1112,1289,12 months,8,0.6206361521
Medicare,TNF,Lung disease,Interstitial lung disease,1112,1289,24 months,19,1.4740108611
Medicare,TNF,Lung disease,Interstitial lung disease,1112,1289,36 months,26,2.0170674942
Medicare,TNF,Lung disease,Interstitial lung disease,1112,1289,AS cohort entry to exposure,9,0.6982156711
Medicare,TNF,Lung disease,Restrictive lung disease ,1112,1289,12 months,52,4.0341349884
Medicare,TNF,Lung disease,Restrictive lung disease ,1112,1289,24 months,84,6.5166795966
Medicare,TNF,Lung disease,Restrictive lung disease ,1112,1289,36 months,95,7.3700543057
Medicare,TNF,Lung disease,Restrictive lung disease ,1112,1289,AS cohort entry to exposure,50,3.8789759503
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,1112,1289,12 months,2,0.155159038
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,1112,1289,24 months,2,0.155159038
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,1112,1289,36 months,3,0.232738557
Medicare,TNF,Neurological Disease,Cauda Equina syndrome,1112,1289,AS cohort entry to exposure,2,0.155159038
Medicare,TNF,Neurological Disease,Spinal Cord compression,1112,1289,12 months,3,0.232738557
Medicare,TNF,Neurological Disease,Spinal Cord compression,1112,1289,24 months,4,0.310318076
Medicare,TNF,Neurological Disease,Spinal Cord compression,1112,1289,36 months,4,0.310318076
Medicare,TNF,Neurological Disease,Spinal Cord compression,1112,1289,AS cohort entry to exposure,3,0.232738557
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,1112,1289,12 months,39,3.0256012413
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,1112,1289,24 months,64,4.9650892164
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,1112,1289,36 months,79,6.1287820016
Medicare,TNF,Osteoporotic fracture,Clinical vertebral fracture,1112,1289,AS cohort entry to exposure,38,2.9480217223
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1112,1289,12 months,42,3.2583397983
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1112,1289,24 months,77,5.9736229635
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1112,1289,36 months,107,8.3010085337
Medicare,TNF,Osteoporotic fracture,Non-vertebral osteoporotic fracture,1112,1289,AS cohort entry to exposure,66,5.1202482545
Medicare,TNF,PsO/PsA,Psoriasis,1112,1289,12 months,75,5.8184639255
Medicare,TNF,PsO/PsA,Psoriasis,1112,1289,24 months,97,7.5252133437
Medicare,TNF,PsO/PsA,Psoriasis,1112,1289,36 months,103,7.9906904577
Medicare,TNF,PsO/PsA,Psoriasis,1112,1289,AS cohort entry to exposure,66,5.1202482545
Medicare,TNF,PsO/PsA,Psoriatic arthritis,1112,1289,12 months,136,10.550814585
Medicare,TNF,PsO/PsA,Psoriatic arthritis,1112,1289,24 months,156,12.102404965
Medicare,TNF,PsO/PsA,Psoriatic arthritis,1112,1289,36 months,161,12.49030256
Medicare,TNF,PsO/PsA,Psoriatic arthritis,1112,1289,AS cohort entry to exposure,128,9.9301784329
Medicare,TNF,Uveitis,Uveitis,1112,1289,12 months,67,5.1978277735
Medicare,TNF,Uveitis,Uveitis,1112,1289,24 months,80,6.2063615206
Medicare,TNF,Uveitis,Uveitis,1112,1289,36 months,92,7.1373157486
Medicare,TNF,Uveitis,Uveitis,1112,1289,AS cohort entry to exposure,65,5.0426687355
